fashion -WSS

fashion

author：explore 2025-09-07 14:03:21 - browse：79

Treeline Northwest — AP Photo/Ted S. Warren

Josh Bilenker’s last company, Loxo Oncology, was purchased by Eli Lilly for $8 billion. No surprise, then, that his next effort has already raised at least $473 million in funding from private investors even before telling the public what, exactly, it is working on.

Treeline Biosciences, the new venture by Bilenker and Jeffrey Engelman, formerly Novartis’s top cancer researcher, has hired more than 130 people across three research sites in little more than a year, according to a company blog post, regulatory filings, and STAT reporting.

Treeline’s website doesn’t mention a single drug target or disease. In a paper published last year in Nature Cancer, Engelman and several colleagues reviewed the history of a class of cancer drugs called PI3 kinase inhibitors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Diagnostic tests are hitting their mathematical limits

knowledge

WSS

Some dementia cases could be undiagnosed liver disease

Novo Nordisk to expand supply of Wegovy for U.S. patients

The real point of Kenneth Smith’s execution by nitrogen gas

ReNAgade cuts staff seven months after raising $300 million

Vertigo drug brings hope for rare neuron disorder, Niemann

Biden administration opens offers in Medicare drug price negotiations

leisure time

fashion

knowledge

Continuity nursing helped my family in our darkest PICU moments

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Fetal surgery at risk from Dobbs and new abortion restrictions

Moonlake's readout produced a cash windfall. Risks remain

BIO selects John Crowley as new CEO

Apple is now the first public company to be valued at $3 trillion

Mayo Clinic plans $5B tech

Alkermes shareholders re

30 years of 'Listening to Prozac'

entertainment

30 years of 'Listening to Prozac'

Vertex non

New Ultima Genomics DNA sequencer can read genome for $100

Time to name cancers by genetics, not organ of origin, expert says

UnitedHealth’s Optum accused of antitrust violations in California

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

focus

hotspot

leisure time

leisure time